-
Shares of Avalo Therapeutics ( NASDAQ: AVTX ) -20.4% after the bell on Thursday after the company said it commenced a proposed underwritten public offering of shares of its common stock and warrants to purchase common shares.
-
All of the shares and warrants in the proposed offering are to be sold by Avalo.
-
Pricing terms of the offering were not disclosed.
-
SVB Securities and RBC Capital Markets are acting as joint bookrunning managers for the offering.
For further details see:
Avalo Therapeutics stock slides 20% after hours on stock and warrants offering